Circulating Osteogenic Precursor Cells in Heterotopic Bone Formation
Robin K. Suda(University of Pennsylvania), Robert J. Pignolo(Mayo Clinic in Arizona), Eileen M. Shore(Fisher & Paykel Healthcare (New Zealand)), Kevin P. Egan(University of Pennsylvania), Paul C. Billings(Children's Hospital of Philadelphia), David Porter(University of Pennsylvania), Ruth McCarrick-Walmsley(University of Pennsylvania), Jung‐Hoon Kim(Seoul National University), David L. Glaser(University of Pennsylvania)
Cited by 127
Related Papers
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1
|Human Mutation|2008|447
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
|Journal of Clinical Oncology|2019|441
Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★
|American Journal of Transplantation|2011|218